Challenges in demand supply management increase the supply chain risk due to node extension and necessitate increased (near) real-time supply chain visibility, multi channel management, and trade compliance. With increasing segmentation, we foresee four distinctive models emerging in the context of pharma distribution. They will be influenced by technological innovations, service focus, healthcare reforms and progress in personalized medicine.
In this paper, we assess three high impact areas that pharmaceuticals companies should streamline for effective supply chain management:
- Inventory visibility
- Sensitive products’ storage and shipments
- Distribution network redesign